Investigational Drug Information for oxfendazole
✉ Email this page to a colleague
What is the drug development status for oxfendazole?
oxfendazole is an investigational drug.
There have been 7 clinical trials for oxfendazole.
The most recent clinical trial was a Phase 1 trial, which was initiated on July 1st 2022.
The most common disease conditions in clinical trials are Trichuriasis, Taeniasis, and Neurocysticercosis. The leading clinical trial sponsors are National Institute of Allergy and Infectious Diseases (NIAID), Universidad Peruana Cayetano Heredia, and Johns Hopkins Bloomberg School of Public Health.
There are three hundred and ten US patents protecting this investigational drug and zero international patents.
Summary for oxfendazole
| US Patents | 310 |
| International Patents | 5,565 |
| US Patent Applications | 1,847 |
| WIPO Patent Applications | 1,013 |
| Japanese Patent Applications | 356 |
| Clinical Trial Progress | Phase 1 (2022-07-01) |
| Vendors | 67 |
Recent Clinical Trials for oxfendazole
| Title | Sponsor | Phase |
|---|---|---|
| Efficacy of Oxfendazole in the Treatment of Trichuris Trichiura Infection in Adults | Universidad Peruana Cayetano Heredia, Lima, Peru | Phase 2 |
| Efficacy of Oxfendazole in the Treatment of Trichuris Trichiura Infection in Adults | Oxfendazole Development Group | Phase 2 |
| PK, Safety and Tolerability of Single and Multiple Doses of Oxfendazole Tablets | Drugs for Neglected Diseases | Phase 1 |
Clinical Trial Summary for oxfendazole
Top disease conditions for oxfendazole
Top clinical trial sponsors for oxfendazole
US Patents for oxfendazole
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| oxfendazole | ⤷ Sign Up | Ethylsulfonated hyaluronic acid biopolymers and methods of use thereof | The Regents of the University of California (Oakland, CA) | ⤷ Sign Up |
| oxfendazole | ⤷ Sign Up | Drug device configured for wireless communication | Pop Test Abuse Deterrent Technology, LLC (Cliffside Park, NJ) | ⤷ Sign Up |
| oxfendazole | ⤷ Sign Up | Fast dissolving pharmaceutical composition | Ferring B.V. (Hoofddorp, NL) | ⤷ Sign Up |
| oxfendazole | ⤷ Sign Up | Parenteral formulations of lipophilic pharmaceutical agents and methods for preparing and using the same | Platform Brightworks Two, Ltd. (Houston, TX) | ⤷ Sign Up |
| oxfendazole | ⤷ Sign Up | Six-membered C--N-bonded aryl sulphide and aryl sulphoxide derivatives as pesticides | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (Monheim am Rhein, DE) | ⤷ Sign Up |
| oxfendazole | ⤷ Sign Up | Anthelmintic compounds | MERIAL INC. (Duluth, GA) | ⤷ Sign Up |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for oxfendazole
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| oxfendazole | European Patent Office | EP2981556 | 2033-04-02 | ⤷ Sign Up |
| oxfendazole | World Intellectual Property Organization (WIPO) | WO2014165513 | 2033-04-02 | ⤷ Sign Up |
| oxfendazole | Australia | AU2015286634 | 2034-07-11 | ⤷ Sign Up |
| oxfendazole | Brazil | BR112017000398 | 2034-07-11 | ⤷ Sign Up |
| oxfendazole | China | CN106659720 | 2034-07-11 | ⤷ Sign Up |
| oxfendazole | European Patent Office | EP3177291 | 2034-07-11 | ⤷ Sign Up |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
